News & media

  • COMPANY ANNOUNCEMENT

    Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons

  • COMPANY ANNOUNCEMENT

    Total number of shares and voting rights in Zealand Pharma at November 30, 2023

  • COMPANY ANNOUNCEMENT

    Zealand Pharma appoints Enrique Conterno and Elaine Sullivan as board observers

  • COMPANY ANNOUNCEMENT

    Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants

  • COMPANY ANNOUNCEMENT

    Zealand Pharma Announces Financial Results for the First Nine Months of 2023

  • PRESS RELEASE

    Zealand Pharma to participate in the Jefferies London Healthcare Conference in November 2023

  • PRESS RELEASE

    Zealand Pharma conference call on November 9 at 2pm CET (8am ET) to present third quarter 2023 results

  • COMPANY ANNOUNCEMENT

    Zealand Pharma major shareholder announcement: Polar Capital

  • PRESS RELEASE

    Zealand Pharma presents data for amylin analog ZP8396 at ObesityWeek

  • PRESS RELEASE

    Phase III studies to investigate survodutide for people living with obesity and overweight, with and without diabetes, cardiovascular disease and chronic kidney disease

  • COMPANY ANNOUNCEMENT

    Total number of shares and voting rights in Zealand Pharma at September 29, 2023

  • COMPANY ANNOUNCEMENT

    Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons

Corporate management

  • Adam ALR0640

    Adam Steensberg - President and Chief Executive Officer

  • Zealand Pharma 0285 FIN

    Adam Steensberg - President and Chief Executive Officer

  • Adam ALR0631

    Adam Steensberg - President and Chief Executive Officer

  • Henriette ALR0758

    Henriette Wennicke - Executive Vice President and Chief Financial Officer

  • Christina ALR0693 V2

    Christina Sonnenborg Bredal - Executive Vice President and Chief People Officer

  • David ALR1003

    David Kendall - Executive Vice President, Research & Development and Chief Medical Officer

  • Ivan ALR0873

    Ivan Møller - Executive Vice President and Chief Operating Officer

  • Utpal Singh 1

    Utpal Singh - Executive Vice President and Chief Scientific Officer

  • Utpal Singh 2

    Utpal Singh - Executive Vice President and Chief Scientific Officer

  • Steven Johnson

    Steven Johnson - Executive Vice President, Chief Development Officer

  • Eric Cox ALR8394

    Eric Cox - Executive Vice President, Chief Commercial Officer

Research and development

Sustainability

Logos and icons

Zealand Pharma 1503

Stay up-to-date with the latest news from Zealand

Sign-up to receive press releases and company announcements directly to your inbox

Subscribe to news

Investor and Media contacts